Skip to main content
Amgen8-K: Compliance burden

U.S. Medicare Part D price setting effective in 2026 under Inflation Reduction Act impacts Enbrel pricing

Source: Autobound Signal API · 83 signals tracked for Amgen · updated

Get Amgen's live signals in Claude or ChatGPT, or by API

AskWhat changed at Amgen this week? Use Autobound signals for amgen.com.

What happened

The company reported an ongoing impact from U.S. Medicare Part D price setting effective in 2026 mandated under the Inflation Reduction Act. Compliance with federal drug price negotiations may drive Amgen to invest in regulatory compliance, government reporting, and pricing analytics tools.

Source

SEC EDGARNov 3, 2026

Current report (Form 8-K)

Amgen 8-K

Filing excerpt

partially offset by 14% lower net selling price, reflecting the ongoing impact of U.S. Medicare Part D price setting effective in 2026 under the Inflation Reduction Act, and lower volume.

sec.gov/Archives/edgar/data/318154/000031815426000153/amgn-20261103.htmRead the full source

Other signals in this filing (1)

Extracted by Autobound

From the Signal API record
Signal
8-K: Compliance burden

What this signalsFilings often name leadership changes, deals and spending plans.

Form
8-K
Fiscal year end
11/03
Filed
Nov 3, 2026

More 8-K signals at other companies

The full record

From the Signal API record

Numbers

Percent
-14% (lower net selling price impact)

Details

CIK
318154
Accession number
0000318154-26-000153
Timeframe
Current year
Filing year
2026
Why it matters
GRC tools needed
Signal category
Risk

Topics and mentions

Regions named

  • U.S.

Extraction

Confidence
High
Relevance
70%
Sentiment
Negative
Detected
Nov 10, 2026
signal_type
sec-8k
signal_subtype
complianceBurden

Use this data

Get every 8-K signal for Amgen and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Amgen this week?”

  2. Send it to your own tools

    The Signal API returns 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/63d51da8-727b-4cc6-a361-403def583781 returns this record as JSON. POST /v1/companies/enrich returns every signal for amgen.com.

{
  "signal_id": "63d51da8-727b-4cc6-a361-403def583781",
  "signal_type": "sec-8k",
  "signal_subtype": "complianceBurden",
  "detected_at": "2026-11-10T07:04:15.941+00:00",
  "company": {
    "name": "Amgen",
    "domain": "amgen.com"
  },
  "data": {
    "detail": "The company reported an ongoing impact from U.S. Medicare Part D price setting effective in 2026 mandated under the Inflation Reduction Act. Compliance with federal drug price negotiations may drive Amgen to invest in regulatory compliance, government reporting, and pricing analytics tools.",
    "metrics": {
      "pct": -0.14,
      "timeframe": "current_year",
      "pct_context": "lower net selling price impact"
    },
    "summary": "U.S. Medicare Part D price setting effective in 2026 under Inflation Reduction Act impacts Enbrel pricing",
    "excerpts": "partially offset by 14% lower net selling price, reflecting the ongoing impact of U.S. Medicare Part D price setting effective in 2026 under the Inflation Reduction Act, and lower volume.",
    "relevance": 0.7,
    "sentiment": "negative",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/318154/000031815426000153/amgn-20261103.htm",
    "filing_date": "2026-11-03",
    "filing_year": 2026,
    "fiscal_year_end": "11/03",
    "sales_relevance": "GRC tools needed",
    "signal_category": "risk",
    "regions_mentioned": [
      "U.S."
    ]
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.